227 related articles for article (PubMed ID: 26865319)
1. An overview about the medical use of antifungals in Portugal in the last years.
Manuel da S Azevedo M; Cruz L; Pina-Vaz C; Gonçalves-Rodrigues A
J Public Health Policy; 2016 May; 37(2):200-15. PubMed ID: 26865319
[TBL] [Abstract][Full Text] [Related]
2. Genesis of Azole Antifungal Resistance from Agriculture to Clinical Settings.
Azevedo MM; Faria-Ramos I; Cruz LC; Pina-Vaz C; Rodrigues AG
J Agric Food Chem; 2015 Sep; 63(34):7463-8. PubMed ID: 26289797
[TBL] [Abstract][Full Text] [Related]
3. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
4. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
Schäfer-Korting M
Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850
[TBL] [Abstract][Full Text] [Related]
5. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
6. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.
Parente-Rocha JA; Bailão AM; Amaral AC; Taborda CP; Paccez JD; Borges CL; Pereira M
Mediators Inflamm; 2017; 2017():9870679. PubMed ID: 28694566
[TBL] [Abstract][Full Text] [Related]
7. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
[TBL] [Abstract][Full Text] [Related]
8. Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?
Hull CM; Purdy NJ; Moody SC
Future Microbiol; 2014; 9(3):307-25. PubMed ID: 24762306
[TBL] [Abstract][Full Text] [Related]
9. Current status of antifungal resistance and its impact on clinical practice.
Alcazar-Fuoli L; Mellado E
Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
[TBL] [Abstract][Full Text] [Related]
10. Medically important fungi respond to azole drugs: an update.
Zavrel M; White TC
Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
[TBL] [Abstract][Full Text] [Related]
11. Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009.
Desai VC; Cavanaugh TM; Kelton CM; Guo JJ; Heaton PC
Clin Ther; 2012 Oct; 34(10):2118-2131.e1. PubMed ID: 23031625
[TBL] [Abstract][Full Text] [Related]
12. Antifungals.
Campoy S; Adrio JL
Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
[TBL] [Abstract][Full Text] [Related]
13. [Antifungals for systemic use].
Ruiz-Camps I; Cuenca-Estrella M
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
[TBL] [Abstract][Full Text] [Related]
14. Combination antifungal therapy: the new frontier.
Vazquez JA
Future Microbiol; 2007 Apr; 2(2):115-39. PubMed ID: 17661650
[TBL] [Abstract][Full Text] [Related]
15. Does the current treatment of invasive fungal infection need to be reviewed?
Martín-Peña A; Aguilar-Guisado M; Cisneros JM
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):523-8. PubMed ID: 23587702
[TBL] [Abstract][Full Text] [Related]
16. Potential targets for the development of new antifungal drugs.
Su H; Han L; Huang X
J Antibiot (Tokyo); 2018 Nov; 71(12):978-991. PubMed ID: 30242283
[TBL] [Abstract][Full Text] [Related]
17. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of antifungal susceptibility: Review of literature.
Hadrich I; Ayadi A
J Mycol Med; 2018 Sep; 28(3):574-584. PubMed ID: 29773435
[TBL] [Abstract][Full Text] [Related]
19. Emerging fungal resistance.
Baddley JW; Moser SA
Clin Lab Med; 2004 Sep; 24(3):721-35, vii. PubMed ID: 15325062
[TBL] [Abstract][Full Text] [Related]
20. Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy.
Hof H
Mycoses; 2008; 51 Suppl 1():1-6. PubMed ID: 18471155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
